[Influence of cytostatic therapy on andrologic findings].
D000818:Animals; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D051379:Mice; D011033:Podophyllin / Q000494:pharmacology; D051381:Rats; D012661:Semen / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects*; D013737:Testis / Q000187:drug effects; D013997:Time Factors; D014228:Triaziquone / Q000494:pharmacology*; D014265:Triethylenemelamine / Q000494:pharmacology
D003520:Cyclophosphamide; D011033:Podophyllin; D014228:Triaziquone; D014265:Triethylenemelamine; D008727:Methotrexate
Die Auswirkungen der cytostaticabehandlung auf den andrologischen Befund.